Baker Bros. Advisors LP Applied Therapeutics Inc. Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$15.44 - $24.23 $587,244 - $921,563
-38,034 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$19.43 - $35.36 $542,097 - $986,544
-27,900 Reduced 42.32%
38,034 $790,000
Q1 2020

May 15, 2020
BUY
$19.54 - $55.47 $1.29 Million - $3.66 Million
65,934 New
65,934 $2.16 Million

Others Institutions Holding APLT

# of Institutions
140
Shares Held
112M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $41.8M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email